By Murray Sherriffs
=
Montreal police are questioning a man who has been caught on video, verbally attacking a number of Jews in Saint-Laurent, shouting “we will kill you” and “you fucking pig” at one man, a member of a Jewish sect.
=
Israel’s flag is flying above Hampstead city hall and Mayor Jeremy Levi says it will stay there, regardless of complaints by some who have aired their discontent on social media.
=
Quebec’s police watchdog (BEI) is investigating a shooting by Montreal police who went to the Campus Rosemont student residence on Bellechasse on the week-end, to investigate a stabbing.
=
A 22-year-old man is dead and two people are in hospital, following a fight in a St. Laurent park.
=
Longueuil Police is investigating a suspicious death of a person found in a burning vehicle in the cemetery on Sir Wilfrid Laurier Boulevard.
=
Air Canada’s flight attendants are refusing to honor a federal government back-to-work order with their union, the Canadian Union of Public Employees saying the order is unconstitutional and “designed to protect the airline’s profit” and has invited the company to go back to the bargaining table and work out ‘…a fair deal.’
=
The REM train that operates between Brossard and Central Station is back in service, following a-month-and-a-half of repairs.
=
An experimental cancer vaccine has shown promise in keeping certain cancers from coming back.
In a phase 1 clinical trial led by the UCLA Health Jonsson Comprehensive Cancer Center, researchers tested the vaccine (ELI-002 2P) with 25 patients who had been treated for pancreatic and colorectal cancer.
All of them had all undergone surgery to remove tumors but were at high risk seeing the cancer return within a year.
The vaccine was given via a series of injections to activate an immune response in the lymph nodes.
A majority (21 out of 25) generated “KRAS-specific T cells,” which indicates a stronger immune response.
The ones with higher T-cell responses showed a longer relapse-free survival compared to those with lower responses.
In three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease biomarkers.
Among the patients who showed the strongest immune response, a majority were still cancer-free nearly 20 months after receiving the vaccine.
The findings were published in Nature Medicine.
=
Sun / 21 today
Cloud / 24 tomorrow
